Case Report
BibTex RIS Cite

PEDİATRİK VON WILLEBRAND OLGULARINDA ANESTEZİK YAKLAŞIM: OLGU SUNUMU

Year 2021, Volume: 7 Issue: 2, 165 - 169, 01.10.2021

Abstract

Koagülasyon 20 değişik plazma proteini veya pıhtılaşma faktörünün katıldığı bir kontrol mekanizmasıdır. Von Willebrand Faktörü (VWF) normal pıhtılaşma mekanizması için gerekli olan bir proteindir. VWF tam yada kısmi eksikliği VWH’a sebep olur. Bu olgu sunumunda genel anestezi altında dental cerrahi girişim yapılan pediatrik bir hastayı ve VWH olgularında anestezi yönetimini tartışmayı amaçladık.

References

  • 1. Meleti M, Vescovi P, Mooi WJ, Van der Waal I. Pigmented lesions of the oral mucosa and perioral tissues: aflow-chart for the diagnosis and some recommendations for the managementOral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:606-16
  • 2. Wilde JT, Cook RJ. Von Willebrand Disease and its management in oral and maxillofacial surgery. Br J Oral Maxillofac Surg 1998; 36(2): 112-18.
  • 3. Federici AB, Castaman G, Thompson A, Berntorp E. Von Willebrand's disease: clinical management. Haemophilia 2006; 12(3): 152-58.
  • 4. Joseph RR. Hematologic Disorders. In: Rose FL, Kaye D. Internal Medicine For Dentistry. St. Louis: The C.V. Mosby Company;1983. p. 407-08
  • 5. Morimoto Y, Yoshioka A, Sugimoto M, Imai Y, Kirita T. Haemostatic management of intraoral bleeding in patients with von Willebrand disease. Oral Dis. 2005; 11(4): 243-48.
  • 6. Israels S, Schwetz N, Boyar R, McNicol A. Bleeding disorders: characterization, dental considerations and management. J Can Dent Assoc 2006; 72(9): 827-827L.)
  • 7. Bongiorno MR, Arico M. Primary malignant melanoma of the oral cavity: case report. Int J Dermatol 2002; 41(3): 178-8
  • 8. Demo PG, Fasolis M, Magiore GMLT, Pagano M, Berrone S. Oral mucosal melanoma: a series of case reports. J Craniomaxillofac Surg 2004; 32 (4): 329-35. 9. Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Blood Coagul Fibrinolysis. 2009; 20: 89-00.
  • 10. Korkmaz İ. Hemophilia and von Willebrand Disease Turkiye Klinikleri J Emerg Med-Special Topics. 2017;3(2):173-83
  • 11. Yücetaş Ş. Ağız ve Çevre Doku Hastalıkları Atlas Kitapçılık Ankara 2005;220-301 Özbayrak S. Ağız Hastalıkları Atlası Tanı Kriterleri Ayrıcı Tanı ve Tedavi Yaklaşımları Quintessence Yayıncılık 2003;212-24
  • 12. Gu GM, Epstein JB, Morton TH. Intraoral melanoma: Long-term follow-up and implication for dental clinicians. A . case report and literature review. Oral Surg Oral Med Pathol Oral Radiol Endod 2003; 96 (4): 404-13.
Year 2021, Volume: 7 Issue: 2, 165 - 169, 01.10.2021

Abstract

References

  • 1. Meleti M, Vescovi P, Mooi WJ, Van der Waal I. Pigmented lesions of the oral mucosa and perioral tissues: aflow-chart for the diagnosis and some recommendations for the managementOral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:606-16
  • 2. Wilde JT, Cook RJ. Von Willebrand Disease and its management in oral and maxillofacial surgery. Br J Oral Maxillofac Surg 1998; 36(2): 112-18.
  • 3. Federici AB, Castaman G, Thompson A, Berntorp E. Von Willebrand's disease: clinical management. Haemophilia 2006; 12(3): 152-58.
  • 4. Joseph RR. Hematologic Disorders. In: Rose FL, Kaye D. Internal Medicine For Dentistry. St. Louis: The C.V. Mosby Company;1983. p. 407-08
  • 5. Morimoto Y, Yoshioka A, Sugimoto M, Imai Y, Kirita T. Haemostatic management of intraoral bleeding in patients with von Willebrand disease. Oral Dis. 2005; 11(4): 243-48.
  • 6. Israels S, Schwetz N, Boyar R, McNicol A. Bleeding disorders: characterization, dental considerations and management. J Can Dent Assoc 2006; 72(9): 827-827L.)
  • 7. Bongiorno MR, Arico M. Primary malignant melanoma of the oral cavity: case report. Int J Dermatol 2002; 41(3): 178-8
  • 8. Demo PG, Fasolis M, Magiore GMLT, Pagano M, Berrone S. Oral mucosal melanoma: a series of case reports. J Craniomaxillofac Surg 2004; 32 (4): 329-35. 9. Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Blood Coagul Fibrinolysis. 2009; 20: 89-00.
  • 10. Korkmaz İ. Hemophilia and von Willebrand Disease Turkiye Klinikleri J Emerg Med-Special Topics. 2017;3(2):173-83
  • 11. Yücetaş Ş. Ağız ve Çevre Doku Hastalıkları Atlas Kitapçılık Ankara 2005;220-301 Özbayrak S. Ağız Hastalıkları Atlası Tanı Kriterleri Ayrıcı Tanı ve Tedavi Yaklaşımları Quintessence Yayıncılık 2003;212-24
  • 12. Gu GM, Epstein JB, Morton TH. Intraoral melanoma: Long-term follow-up and implication for dental clinicians. A . case report and literature review. Oral Surg Oral Med Pathol Oral Radiol Endod 2003; 96 (4): 404-13.
There are 11 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Report
Authors

Cem Ece 0000-0002-5786-0525

Şeyda Canlı 0000-0002-6568-8032

Publication Date October 1, 2021
Submission Date May 26, 2021
Published in Issue Year 2021 Volume: 7 Issue: 2

Cite

Vancouver Ece C, Canlı Ş. PEDİATRİK VON WILLEBRAND OLGULARINDA ANESTEZİK YAKLAŞIM: OLGU SUNUMU. Aydin Dental Journal. 2021;7(2):165-9.

All site content, except where otherwise noted, is licensed under a Creative Common Attribution Licence. (CC-BY-NC 4.0)